{"id":8268,"date":"2022-02-15T09:25:00","date_gmt":"2022-02-15T14:25:00","guid":{"rendered":"https:\/\/transfusionontario.org\/?p=8268"},"modified":"2024-07-25T09:45:28","modified_gmt":"2024-07-25T13:45:28","slug":"february-2022","status":"publish","type":"post","link":"https:\/\/transfusionontario.org\/en\/february-2022\/","title":{"rendered":"Massive Hemorrhage Protocol: Quality Metrics Portal Pilot"},"content":{"rendered":"<div class=\"wp-block-image is-resized\">\n<figure class=\"alignleft size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo-1024x512.png\" alt=\"\" class=\"wp-image-8271\" style=\"width:334px;height:auto\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo-1024x512.png 1024w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo-300x150.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo-768x384.png 768w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo-110x55.png 110w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/mhp_logo.png 1501w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Troy Thompson, ORBCoN Program Manager, Dr. Jeannie Callum, Director of Transfusion Medicine, Kingston Health Sciences Centre<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Background<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A Quality Metrics reporting portal has been developed to capture 8 MHP quality metrics as defined in the Provincial Massive Hemorrhage Protocol toolkit. The portal will be interfaced with a \u201cdashboard\u201d or data visualization tool which will provide a dynamic and interactive tool allowing users to quickly visualize and evaluate their metrics over time as well as against provincial benchmarks.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Methods<\/strong><br><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">An electronic data tool (reporting portal) was developed to capture the 8 quality metrics listed below. Additional demographic information was added to the data entry process to allow for comparisons between specific variables (age range, type of hemorrhage, etc). A pilot of the MHP Quality Metrics Portal included 6 hospital sites.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The 8 quality metrics recommended for reporting in the MHP Quality Metrics portal:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The proportion of patients receiving tranexamic acid within 1 hour of protocol activation.<\/li>\n\n\n\n<li>The proportion of patients in whom RBC transfusion is initiated within 15 minutes of protocol activation.<\/li>\n\n\n\n<li>The proportion of patients (requiring transfer for definitive care) with initiation of call for transfer within 60 minutes of protocol activation.<\/li>\n\n\n\n<li>The proportion of patients achieving a temperature &gt;35\u2070C at termination of the protocol.<\/li>\n\n\n\n<li>The proportion of patients with hemoglobin levels maintained between 60-110 g\/L during protocol activation, excluding certain pediatric populations (e.g., neonates) that may require higher hemoglobin values.<\/li>\n\n\n\n<li>The proportion of patients transitioned to group specific RBCs and plasma within 90 minutes of arrival\/onset of hemorrhage.<\/li>\n\n\n\n<li>The proportion of patients with appropriate activation (&gt;6 RBC units in first 24 hours; &gt;40 ml\/kg\/24 hours of RBCs in pediatric patients) or before this level in patients dying due to hemorrhage within 24 hours.<\/li>\n\n\n\n<li>The proportion of patients without any blood component wastage (including plasma that is thawed and not used within the 5 day limit on another patient).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The purpose of the pilot was to assess the feasibility of data collection at hospital sites and to \u201cinterrogate\u201d the MHP Quality Metrics portal to ensure the data entry and reporting mechanism were validated and the results presented would be relevant to assess MHP processes.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Results<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The pilot results as of January 20, 2022 included 6 hospital sites and their MHP activations. During the reporting period (ranging from January 2019 to December 2021), 309 MHP activations were reported into the MHP portal.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Demographic Results<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Figure 1. Hospital Location of MHP Activation<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"756\" height=\"432\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-1.-Hospital-Location-of-MHP-Activation.png\" alt=\"\" class=\"wp-image-8282\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-1.-Hospital-Location-of-MHP-Activation.png 756w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-1.-Hospital-Location-of-MHP-Activation-300x171.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-1.-Hospital-Location-of-MHP-Activation-110x63.png 110w\" sizes=\"auto, (max-width: 756px) 100vw, 756px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 2. Age Ranges for MHP Activations<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"756\" height=\"431\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-2.-Age-Ranges-for-MHP-Activations.png\" alt=\"\" class=\"wp-image-8284\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-2.-Age-Ranges-for-MHP-Activations.png 756w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-2.-Age-Ranges-for-MHP-Activations-300x171.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-2.-Age-Ranges-for-MHP-Activations-110x63.png 110w\" sizes=\"auto, (max-width: 756px) 100vw, 756px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Quality Metrics Results<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 3. The number of MHP activations (cases) receiving tranexamic acid within 1 hour of protocol activation.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"704\" height=\"304\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-3.-MHP-activations-receiving-tranexamic-acid.png\" alt=\"\" class=\"wp-image-8286\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-3.-MHP-activations-receiving-tranexamic-acid.png 704w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-3.-MHP-activations-receiving-tranexamic-acid-300x130.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-3.-MHP-activations-receiving-tranexamic-acid-110x48.png 110w\" sizes=\"auto, (max-width: 704px) 100vw, 704px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 4. The number of MHP activations (cases) with RBC transfusion initiated within 15 minutes of protocol activation.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"785\" height=\"397\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-4.-MHP-activations-cases-with-RBC.png\" alt=\"\" class=\"wp-image-8288\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-4.-MHP-activations-cases-with-RBC.png 785w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-4.-MHP-activations-cases-with-RBC-300x152.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-4.-MHP-activations-cases-with-RBC-768x388.png 768w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-4.-MHP-activations-cases-with-RBC-110x56.png 110w\" sizes=\"auto, (max-width: 785px) 100vw, 785px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 5. The number\/percentage of MHP activations where the initiation for patient transfer was within 60 minutes of protocol activation.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"585\" height=\"238\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-5.-MHP-activations-patient-transfer.png\" alt=\"\" class=\"wp-image-8290\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-5.-MHP-activations-patient-transfer.png 585w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-5.-MHP-activations-patient-transfer-300x122.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-5.-MHP-activations-patient-transfer-110x45.png 110w\" sizes=\"auto, (max-width: 585px) 100vw, 585px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 6. The number\/percentage of MHP activations where the patient&#8217;s temperature was \u2265 35\u2070C at termination of protocol? (30 minutes prior to\/after termination).<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"283\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-6.-MHP-activations-patients-temperature.png\" alt=\"\" class=\"wp-image-8292\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-6.-MHP-activations-patients-temperature.png 568w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-6.-MHP-activations-patients-temperature-300x149.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-6.-MHP-activations-patients-temperature-110x55.png 110w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 7. The number\/percentage of MHP activations where the patient\u2019s hemoglobin was maintained over 60 g\/L in the first 24 hours?<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"607\" height=\"250\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-7.-MHP-activations-patientu2019s-hemoglobin.png\" alt=\"\" class=\"wp-image-8294\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-7.-MHP-activations-patientu2019s-hemoglobin.png 607w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-7.-MHP-activations-patientu2019s-hemoglobin-300x124.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-7.-MHP-activations-patientu2019s-hemoglobin-110x45.png 110w\" sizes=\"auto, (max-width: 607px) 100vw, 607px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 8. The number\/percentage of MHP activations where the patient\u2019s hemoglobin was &lt;110 g\/L at 24 hours.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"612\" height=\"247\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-8.-MHP-activations-patientu2019s-hemoglobin.png\" alt=\"\" class=\"wp-image-8296\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-8.-MHP-activations-patientu2019s-hemoglobin.png 612w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-8.-MHP-activations-patientu2019s-hemoglobin-300x121.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-8.-MHP-activations-patientu2019s-hemoglobin-110x44.png 110w\" sizes=\"auto, (max-width: 612px) 100vw, 612px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 9. The number\/percentage of MHP activations where the patient was transitioned to group specific RBC\/Plasma within 90 minutes of MHP activation.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"731\" height=\"291\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-9.-MHP-activations-patient-transitioned-to-group-specific-RBC-Plasma.png\" alt=\"\" class=\"wp-image-8298\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-9.-MHP-activations-patient-transitioned-to-group-specific-RBC-Plasma.png 731w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-9.-MHP-activations-patient-transitioned-to-group-specific-RBC-Plasma-300x119.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-9.-MHP-activations-patient-transitioned-to-group-specific-RBC-Plasma-110x44.png 110w\" sizes=\"auto, (max-width: 731px) 100vw, 731px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 10. The number\/percentage of MHP activations that were appropriate.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"553\" height=\"187\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-10.-MHP-activations-that-were-appropriate..png\" alt=\"\" class=\"wp-image-8300\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-10.-MHP-activations-that-were-appropriate..png 553w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-10.-MHP-activations-that-were-appropriate.-300x101.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-10.-MHP-activations-that-were-appropriate.-110x37.png 110w\" sizes=\"auto, (max-width: 553px) 100vw, 553px\" \/><figcaption class=\"wp-element-caption\">*(&gt;6 RBCs in 1st 24 hours; &gt;40 mL\/kg\/24 hours of RBCs in pediatric population or below these levels in patients expiring due to hemorrhage within 24 hours)<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Figure 11. The number\/percentage of MHP activations where there was wastage of blood products.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"342\" height=\"155\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-11.-MHP-activations-with-wastage-of-blood-products.png\" alt=\"\" class=\"wp-image-8302\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-11.-MHP-activations-with-wastage-of-blood-products.png 342w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-11.-MHP-activations-with-wastage-of-blood-products-300x136.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Figure-11.-MHP-activations-with-wastage-of-blood-products-110x50.png 110w\" sizes=\"auto, (max-width: 342px) 100vw, 342px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Conclusion<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The data entry pilot provided valuable information regarding the data entry and reporting mechanism of the portal. Modifications to the data entry fields were completed during the pilot to allow for more complete data entry at the participating sites. Additional feedback from the MHP Quality working group will be incorporated into the portal prior to launch.<br>The portal and associated data \u201cdashboard\u201d will be useful in monitoring an institution\u2019s MHP activities and support quality improvement activities where required.<br>The MHP Quality Metrics portal will be officially launched soon and more information on how to access the portal will be provided at that time. For information on how the metrics were determined for local and provincial reporting, we invite you to watch an archived presentation from Dr. Avery Nathans <a href=\"https:\/\/transfusionontario.org\/massive-hemorrhage-protocol-quality-outcome-tips-on-monitoring\/\">Click here<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ORBCoN would like to thank the participating hospitals who contributed to the exercise to validate the reporting tool.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/transfusionontario.org\/category\/massive-hemorrhage-protocol\/toolkit\/\">Click here<\/a> to find more information related to the provincial MHP and MHP quality metrics.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Quality-Metrics-Portal.png\" alt=\"\" class=\"wp-image-8273\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Quality-Metrics-Portal.png 500w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Quality-Metrics-Portal-300x300.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Quality-Metrics-Portal-150x150.png 150w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Quality-Metrics-Portal-110x110.png 110w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"TM-web-conference\">Register: 17th Annual Transfusion Medicine Education Web Conference<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/TM-Conference-Save-the-Date-NL.png\" alt=\"\" class=\"wp-image-8275\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/TM-Conference-Save-the-Date-NL.png 500w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/TM-Conference-Save-the-Date-NL-300x300.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/TM-Conference-Save-the-Date-NL-150x150.png 150w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/TM-Conference-Save-the-Date-NL-110x110.png 110w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius wp-element-button\" style=\"background-color:#083459\"><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\">Click Here To Register<\/span><\/a><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"perinatal-conference\">Save the Date: Perinatal Consensus Conference<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Perinatal-Consensus-Conference-NL.png\" alt=\"\" class=\"wp-image-8277\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Perinatal-Consensus-Conference-NL.png 500w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Perinatal-Consensus-Conference-NL-300x300.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Perinatal-Consensus-Conference-NL-150x150.png 150w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/Perinatal-Consensus-Conference-NL-110x110.png 110w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"MHP-Simulation\">Featured Resource: MHP Simulation Videos<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Simulation-Videos.png\" alt=\"\" class=\"wp-image-8279\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Simulation-Videos.png 500w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Simulation-Videos-300x300.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Simulation-Videos-150x150.png 150w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2022\/02\/MHP-Simulation-Videos-110x110.png 110w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius wp-element-button\" style=\"background-color:#083459\"><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\">Click Here To Watch<\/span><\/a><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"Uoft-TM\">Upcoming Event: University of Toronto Transfusion Medicine Rounds<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2021\/10\/UofT-TM-Rounds.png\" alt=\"\" class=\"wp-image-7672\" style=\"width:490px;height:auto\" srcset=\"https:\/\/transfusionontario.org\/wp-content\/uploads\/2021\/10\/UofT-TM-Rounds.png 800w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2021\/10\/UofT-TM-Rounds-300x169.png 300w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2021\/10\/UofT-TM-Rounds-768x432.png 768w, https:\/\/transfusionontario.org\/wp-content\/uploads\/2021\/10\/UofT-TM-Rounds-110x62.png 110w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>February 24th, 2022 @ 12:00 pm \u2013 1:00 pm<br><\/strong>Using Blood Wisely Progress Report presented by Dr. Yulia Lin<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius wp-element-button\" href=\"https:\/\/transfusionontario.org\/event\/university-of-toronto-transfusion-medicine-rounds-february-24-2022\/\" style=\"background-color:#083459\"><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\">Click Here For More Information<\/span><\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Troy Thompson, ORBCoN Program Manager, Dr. Jeannie Callum, Director of Transfusion Medicine, Kingston Health Sciences Centre Background A Quality Metrics reporting portal has been developed to capture 8 MHP quality [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":8269,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_tec_requires_first_save":true,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","footnotes":""},"categories":[137],"tags":[],"class_list":["post-8268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter"],"acf":[],"_links":{"self":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/posts\/8268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/comments?post=8268"}],"version-history":[{"count":0,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/posts\/8268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/media\/8269"}],"wp:attachment":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/media?parent=8268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/categories?post=8268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/tags?post=8268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}